ITA No. 1811/DEL/2020 covers the appeal by Akums Drugs & Pharmaceuticals Ltd. against the decision of the Deputy Commissioner of Income Tax (DCIT), Circle 2(1), New Delhi, for the assessment year 2013-14. This article explores the circumstances and legal nuances surrounding the withdrawal of this appeal.
The appeal was part of a series, including ITA Nos. 1810 and 1812, which contested the orders of the ld. CIT (Appeals)-I, New Delhi. These orders addressed assessments for the years 2012-13, 2013-14, and 2014-15.
On November 22, 2022, during the tribunal proceedings, the counsel for Akums Drugs & Pharmaceuticals Ltd. requested permission to withdraw the appeal. The legal representative of the Revenue raised no objections to this request. Consequently, the Tribunal allowed the withdrawal of the appeal, leading to its dismissal as withdrawn.
The decision to withdraw an appeal involves strategic legal considerations. For Akums Drugs & Pharmaceuticals Ltd., the choice to withdraw may have been influenced by a variety of factors, including the reassessment of the potential outcomes, the financial implications of continuing litigation, or new developments in the legal or factual aspects of the cases.
The withdrawal marks the end of the tribunal proceedings for the assessment year 2013-14 for Akums Drugs & Pharmaceuticals Ltd. This case illustrates the procedural aspects of appeal withdrawals and highlights the importance of strategic decision-making in corporate litigation. The dismissal of the appeal as withdrawn concludes the matter without further examination of the substantive issues originally contested.
Overview of Withdrawal of Appeal by Akums Drugs & Pharmaceuticals Ltd. in ITA 1811/DEL/2020
Manage the increasing number of hearings effortlessly by leveraging the legal AI revolution We are India's Leading revolutionary AI-powered legal platform where you can get enough insights into top cases and judgements.
Research Platform